Bristol Myers Squibb (NYSE: BMY) reported web revenue for the primary quarter of 2025, in comparison with a loss final yr. The biotechnology firm’s revenues declined 6% in Q1.
Internet earnings attributable to shareholders was $2.46 million or $1.20 per share within the March quarter, in comparison with a lack of $11.9 billion or $5.89 per share within the comparable interval final yr. Adjusted revenue was $1.80 per share in Q1, in comparison with a loss per share of $4.40 within the first quarter of 2024.
March-quarter revenues decreased 6% from final yr to $11.2 billion. The corporate raised its full-year 2025 adjusted earnings per share steering to a spread of $6.70 to $7.00.
